Nishant Shah, MD
@Nishant_ShahMD
Followers
2K
Following
8K
Media
150
Statuses
2K
Preventive Cardiologist @DukeHeartCenter @DCRINews | APD @DukeCardFellows | Alum of @CCFcards @OslerResidency | Father and Husband | Tweets are my own
Durham, NC
Joined November 2018
Feel lucky to share this experience with this wonderful group! Looking forward to the journey ahead! Thank you @ACCinTouch for the opportunity!
American College of Cardiology #Leadership Accelerator kickoff in DC: full weekend exploring leadership strengths, transformational change, and building confidence for leadership in a complex #healthcare world 🫀 Key themes: embrace discomfort, develop top strengths over lesser
0
0
10
A REVEAL paper—including @Nishant_ShahMD; Lauren Cohen, MA, PMP; @manesh_patelMD; Dr. Suresh Mulukutla; Dr. Steve Bradley; @texhern & @NPagidipati—found 60% of patients w #ASCVD had uncontrolled LDL-C & highlights the urgent need to improve equitable care: https://t.co/JRCEk8zCGl
0
3
9
Thank you @azinkh96 and @SMosteoru for inviting me to #AtheroTalk. I enjoyed our conversation on the evolving science and practice of preventive cardiology and lipid management, and the chance to look ahead at where the field is going! @EASociety @ASPCardio @Kpakanati3
🎙️ A new #AtheroTalk episode featuring @DrMichaelShapir is released ! An incredible conversation that I found myself taking notes again on replay. Don’t miss it! Spotify: https://t.co/adTJ3db3qt Apple Podcasts: https://t.co/0g9MmEwIXt YouTube: https://t.co/dlivIrxZRd
2
4
26
Looking forward to seeing these results! Important milestone in high risk patients without a prior event, a group that needs aggressive LDL-C lowering
📢NEWS: Amgen announces topline results from its Phase 3 trial evaluating cardiovascular outcomes in high-risk patients without prior heart attack or stroke. Full data readout at @American_Heart Scientific Sessions #AHA25. 🔗 Learn more: https://t.co/yq59tLVXgr $AMGN
0
0
4
This month we’re highlighting the @AllianceCardio REVEAL study led by @DCRINews @NPagidipati & @Nishant_ShahMD. This study offers new insights on clinical practice patterns for atherosclerotic cardiovascular disease #ASCVD. Learn more: https://t.co/wztMCCgKQP
0
2
8
Optimal management of atherosclerotic cardiovascular disease (ASCVD), the leading cause of death in the United States and worldwide, is a key clinical and public health priority. The American Heart Association National Integrated ASCVD Initiative provides a foundation for
2
6
17
Thrilled to see my close friend and colleague @EstherSHKimMD put together and Chair an outstanding #VSS2025 and officially begin her term as #SVM President! Excited for the impact she will make !! @SVM_tweet @ASPCardio @AtriumHealth @wakeforestmed
4
3
40
Amazing discussion on lipid management with specialists across the Carolinas at the @ACCNCChapter meeting! Stronger together! @DukeHealth @DukeHeartCenter @UNC_Health_Care @UNCCardiology @ConeHeartVasc @AtriumHealth @NovantHealth @HCAhealthcare @ECUCards @theprismahealth
0
1
6
6
3
55
Join our @ACCinTouch #Prevention Council & renowned experts for a review of the new #Hypertension guidelines @ 1pm on 9/17. @DrEugeneYang Dr. Joseph Ebinger @Lesliedavis @EileenHandberg Dr. Keith Ferdinand @American_Heart @nationallipid @ASPCardio
https://t.co/cKl5lLGCdY
0
8
28
Such a fun @DukeCardFellows journal club discussing the BaxHTN trial! Way to go @aarti693! @manesh_patelMD @DukeHeartCenter @NPagidipati @MDKelseyMD @camfrazmills
1
2
41
The @AllianceCardio Test 2 Treat study combines an inpatient, hospital-level intervention & an outpatient, patient-level, randomized intervention to improve LDL cholesterol testing & treatment in 6 health systems. Learn more: https://t.co/0Pru0QZW53
0
1
4
I am grateful to Dr @spjuraschek who made time to discuss with me how the new @American_Heart @ACCinTouch #BloodPressure #Guidelines which were ⭐️ @AHAScience discussions at #Hypertension25 will impact his #ClinicalPractice 🙏 Stephen
0
5
16
The @AllianceCardio Test 2 Treat study is looking at real-world data from EHRs & patient-reported outcomes to learn if providing education to doctors & patients who have had a heart event works to prevent future heart problems. Learn more: https://t.co/0Pru0QZW53
0
1
6
Day 3 of #ESCCongress features presentations from Renato Lopes, @NPagidipati, @SJGreene_md, and Sana Al-Khatib! Check back tomorrow for the last day's sessions.
0
2
8
Get ready for day 2 of #ESCCongress! Today's lineup features sessions with Christopher Granger, @SJGreene_md, Sana Al-Khatib, Renato Lopes, @NPagidipati, and Jennifer Rymer.
1
2
11
The @AllianceCardio's @JavedButler1, @NPagidipati, @Nishant_ShahMD, and @AndrewPAmbrosy are presenting at #ESCCongress in Madrid this weekend! Check out the program for details:
0
3
6
Looking forward to presenting our findings in patients with premature ASCVD and elevated Lp(a)! Come join us!
It's the first day of #ESCCongress! We'll be posting rundowns of DCRI sessions each day of the conference. Today, DCRI's @Nishant_ShahMD will be sharing his presentation on comorbidities and prognosis in chronic coronary syndromes.
1
0
11
A new publication including @AllianceCardio's @Nishant_ShahMD describes the @AHAScience National ASCVD Initiative to implement multiple approaches to improve lipid management & outcomes for patients with #ASCVD. Read the article: https://t.co/e9WgnvMOPW
1
2
9